Fundraising Fox

Apollo Therapeutics

Cambridge, GB · 66 employees on LinkedIn · 4 known investors

Find your way into Apollo Therapeutics

A portfolio biopharmaceutical company that translates breakthroughs in biology and basic medical research from top universities into novel therapeutics. The company develops a diversified pipeline of drug candidates across multiple therapeutic areas, with partnerships spanning six leading UK research institutions.

BiotechHealthtech

Investors · 4

Patient Square Capital✓ verifiedMenlo Park
Rock Springs Capital✓ verifiedBaltimore
AlbionVCLondon
UCL Technology FundLondon · $320K – $9M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Apollo Therapeutics Announces Second Close Of Series C Financing Bringing Total Raised In Round To $260 Million | Apollo Therapeuticsapollotx.com · Jan 2024£180m+ funding medicine for Apollo Therapeuticsbusinesscloud.co.uk · Sep 2023Apollo Therapeutics raises $226.5m to develop medicines based on uni research | Imperial News | Imperial College Londonimperial.ac.uk · Sep 2023Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital | Apollo Therapeuticsapollotx.com · Sep 2023Team | Apollo Therapeuticsapollotx.com · Jul 2023About Us | Apollo Therapeuticsapollotx.com · Jul 2023

Frequently asked questions

What does Apollo Therapeutics do?
A portfolio biopharmaceutical company that translates breakthroughs in biology and basic medical research from top universities into novel therapeutics. The company develops a diversified pipeline of drug candidates across multiple therapeutic areas, with partnerships spanning six leading UK research institutions.
Who are Apollo Therapeutics's investors?
Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, AlbionVC, UCL Technology Fund.
Where is Apollo Therapeutics headquartered?
Apollo Therapeutics is headquartered in Cambridge, GB.